NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced results of a review conducted by the Data Safety and Monitoring Board (DSMB) on May 25,...
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatment Response Monitoring Kit...
ELEVAI LABS, INC., ("ELEVAI" or the "Company") a science-based, data-driven regenerative aesthetic skincare company is pleased to announce it has retained Univest Securities, LLC...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company"), announced that the first subject has been dosed in the Company's Phase 1a single ascending dose...
